Matches in SemOpenAlex for { <https://semopenalex.org/work/W2022505648> ?p ?o ?g. }
Showing items 1 to 47 of
47
with 100 items per page.
- W2022505648 endingPage "735" @default.
- W2022505648 startingPage "735" @default.
- W2022505648 abstract "Epinastine is a potent antiallergic agent that has not only antihistaminic (H(1)) properties but also provides antileukotriene, anti-PAF and antibradykinin activities, which are associated with its antiallergic actions. Moreover, epinastine is very effective in inhibiting the release of chemical mediators from mast cells exposed to antigen. In addition, IL-8 release from eosinophils was inhibited by epinastine posttranscriptionally. Chemotatic movement of eosinophils was also blocked by epinastine. The increase in EEG power spectrum at low frequency region detected at frontal cortex is associated with drowsiness. No such change was induced by epinastine, while a marked increase was observed after ketotifen. In agreement with this, when the amount of H(1) blockers that penetrated through the BBB into the brain was estimated by means of PET, it was apparent that epinastine hardly penetrated the BBB. With regard to the current-voltage relationship of HERG currents, epinastine did not affect I(Kr), while a marked inhibition was seen after terfenadine or astemizole. These results indicated that epinastine does not suppress delayed rectifier potassium current of the heart and, consequently, no cardiotoxic action of epinastine was postulated. In man, epinastine is readily absorbed after oral administration and no significant change in pharmacokinetics was found during chronic administration. In teratological studies in rats, malformation and variation were not observed even at high doses of epinastine. In the clinical application of epinastine, it was shown that this drug is remarkably effective in the treatment of various dermatological diseases, such as chronic urticaria, psoriasis vulgaris and other pruritic dermatoses. Moreover, epinastine provides excellent clinical efficacy in the treatment of allergic rhinitis. Although efficacy of H(1) blockers in bronchial asthma is somewhat doubtful, the overall improvement rate in asthmatic patients was significantly higher in epinastine-treated patients (53.7%) compared to those treated with ketotifen (25%)." @default.
- W2022505648 created "2016-06-24" @default.
- W2022505648 creator A5091258949 @default.
- W2022505648 date "2000-01-01" @default.
- W2022505648 modified "2023-09-30" @default.
- W2022505648 title "Epinastine: An update of its pharmacology, metabolism, clinical efficacy and tolerability in the treatment of allergic diseases" @default.
- W2022505648 doi "https://doi.org/10.1358/dot.2000.36.11.1136048" @default.
- W2022505648 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12845334" @default.
- W2022505648 hasPublicationYear "2000" @default.
- W2022505648 type Work @default.
- W2022505648 sameAs 2022505648 @default.
- W2022505648 citedByCount "20" @default.
- W2022505648 countsByYear W20225056482019 @default.
- W2022505648 countsByYear W20225056482020 @default.
- W2022505648 countsByYear W20225056482022 @default.
- W2022505648 crossrefType "journal-article" @default.
- W2022505648 hasAuthorship W2022505648A5091258949 @default.
- W2022505648 hasConcept C2776129107 @default.
- W2022505648 hasConcept C2779303165 @default.
- W2022505648 hasConcept C71924100 @default.
- W2022505648 hasConcept C98274493 @default.
- W2022505648 hasConceptScore W2022505648C2776129107 @default.
- W2022505648 hasConceptScore W2022505648C2779303165 @default.
- W2022505648 hasConceptScore W2022505648C71924100 @default.
- W2022505648 hasConceptScore W2022505648C98274493 @default.
- W2022505648 hasIssue "11" @default.
- W2022505648 hasLocation W20225056481 @default.
- W2022505648 hasLocation W20225056482 @default.
- W2022505648 hasOpenAccess W2022505648 @default.
- W2022505648 hasPrimaryLocation W20225056481 @default.
- W2022505648 hasRelatedWork W1987575117 @default.
- W2022505648 hasRelatedWork W2016523948 @default.
- W2022505648 hasRelatedWork W2061025681 @default.
- W2022505648 hasRelatedWork W2072811285 @default.
- W2022505648 hasRelatedWork W2090869718 @default.
- W2022505648 hasRelatedWork W2095122837 @default.
- W2022505648 hasRelatedWork W2129867925 @default.
- W2022505648 hasRelatedWork W2161927647 @default.
- W2022505648 hasRelatedWork W66110367 @default.
- W2022505648 hasRelatedWork W1759177440 @default.
- W2022505648 hasVolume "36" @default.
- W2022505648 isParatext "false" @default.
- W2022505648 isRetracted "false" @default.
- W2022505648 magId "2022505648" @default.
- W2022505648 workType "article" @default.